References
(1) M A Heffernan, W J Jiang, A W Thorburn, and F M Ng (2000) Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism – Am J Physiol Endocrinol Metab, 2000 Sep, Volume 279 (Issue 3), Pages E501-7.
(2) M Heffernan, R J Summers, A Thorburn, E Ogru, et al (2001) The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice – Endocrinology, 2001 Dec, Volume 142 (Issue 12), Pages 5182-9.
(3) F M Ng and J Bornstein (1978) Hyperglycemic action of synthetic C-terminal fragments of human growth hormone – American Journal of Physiology, 1978 May, Volume 234 (Issue 5), Pages E521-6.
(4) Dong Rak Kwon and Gi Young Park (2015) Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model – Annals of Clinical and Laboratory Science, 2015 Summer, Volume 45 (Issue 4), Pages 426-32.
(5) M M Habibullah, S Mohan, Nl Kashan Syed, H A Makeen, et al (2022) Human Growth Hormone Fragment 176–191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells – Drug Design, Development and Therapy, 2022 Jun 27, Volume 16, Pages 1963–1974.